The Experts below are selected from a list of 2529 Experts worldwide ranked by ideXlab platform
Jack Dekker - One of the best experts on this subject based on the ideXlab platform.
-
moderation of the alliance outcome association by prior depressive episodes differential effects in cognitive behavioral therapy and short term psychodynamic Supportive Psychotherapy
Behavior Therapy, 2017Co-Authors: Lorenzo Lorenzoluaces, Ellen Driessen, Mariëlle Hendriksen, Robert J Derubeis, John R Keefe, Jack DekkerAbstract:Abstract Prior studies have suggested that the association between the alliance and depression improvement varies as a function of prior history of depression. We sought to replicate these findings and extend them to short-term psychodynamic Supportive Psychotherapy (SPSP) in a sample of patients who were randomized to one of these treatments and were administered the Helping Alliance Questionnaire ( N = 282) at Week 5 of treatment. Overall, the alliance was a predictor of symptom change ( d = 0.33). In SPSP, the alliance was a modest but robust predictor of change, irrespective of prior episodes ( d = 0.25–0.33). By contrast, in CBT, the effects of the alliance on symptom change were large for patients with 0 prior episodes ( d = 0.86), moderate for those with 1 prior episode ( d = 0.49), and small for those with 2 + prior episodes ( d = 0.12). These findings suggest a complex interaction between patient features and common vs. specific therapy processes. In CBT, the alliance relates to change for patients with less recurrent depression whereas other CBT-specific processes may account for change for patients with more recurrent depression.
-
A Short-term Psychodynamic Supportive Psychotherapy for Adolescents with Depressive Disorders: A New Approach
Journal of Infant Child and Adolescent Psychotherapy, 2016Co-Authors: Linda Dil, Rien Van, Jack Dekker, Frans SchalkwijkAbstract:ABSTRACTDepression is one of the most common psychiatric disorders in both adolescents and adults. In this article, we introduce Short-term Psychodynamic Supportive Psychotherapy (SPSP) for adolescents, a relatively new form of psychodynamic therapy for depression that has been studied in a range of randomized controlled trials with adult patients. SPSP emphasizes the relational aetiology and significance of depression and is characterized by a Supportive attitude which focuses more on working in the here-and-now relational patterns rather than interpreting transference manifestations. The Supportive attitude of the therapist is advocated to engage the adolescent in the therapeutic relationship and to foster his or her innate developmental capacities by attending to previously unaddressed developmental needs. The developmental perspective’s interest in defense styles and stagnation resulting from problems in past and current relationships opens up opportunities for acquiring insight and change. The focus ...
-
short term psychoanalytic Supportive Psychotherapy for depressed patients
Psychoanalytic Inquiry, 2013Co-Authors: Frans De Jonghe, Mariëlle Hendriksen, Simone Kool, Saskia De Maat, Rien Van, M Gerda D Van Aalst, Jack DekkerAbstract:Short-Term Psychoanalytic Supportive Psychotherapy (SPSP) is a face-to-face, individual Psychotherapy, consisting of sixteen sessions in six months (first eight weekly, then eight fortnightly sessions). It is rooted in psychoanalytic theory. Its primary aim is to cure depression. A secondary goal is to reduce a patient's vulnerability to depression. The emphasis is on Supportive techniques that counter regression and foster psychological growth. The putative process consists in experiencing a relational dissonance, i.e., feeling two contradictory relationships in the therapeutic situation simultaneously, one determined by the past, the other by the present. We assume an important curative factor is to experience, mostly unconsciously, an adequate gratification of developmental needs inadequately met in early infancy and, therefore, manifesting themselves in the archaic aspects of the therapeutic relationship. SPSP unfolds as a discourse in which we distinguish nine levels. Each regards a specific subject,...
-
speed of action the relative efficacy of short psychodynamic Supportive Psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression
Journal of Affective Disorders, 2008Co-Authors: Jack Dekker, Henricus L. Van, Robert A. Schoevers, Simone Kool, Jaap Peen, Jurrijn Koelen, M Hendriksen, G Van Aalst, F De JongheAbstract:Abstract Objective To examine the efficacy and speed of action of short-term psychodynamic Supportive Psychotherapy (SPSP) in comparison to pharmacotherapy (PhT) in the acute treatment of depression. Method This study reported on the first 8 weeks of a treatment algorithm for depression. 70 patients with a depressive episode according to DSM-IV were randomized to PhT, 71 patients were randomized to SPSP. The acceptability of the Psychotherapy was greater than pharmacotherapy. Results At the end of the first 8 weeks of treatment, attrition rates were similar in both conditions. PhT-patients were better off at 4 weeks according to two of the four measures The superiority of PhT was clearer on the self-report than on the independent measure. Conclusions There are signs that the benefits of PhT over SPSP—where detected—are short-lived and cover mostly the first month of treatment. The progression of these patients through the rest of their treatments, and afterwards, will be reported in further contributions.
-
Short psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials
Depression and Anxiety, 2008Co-Authors: Saskia De Maat, Gerda Van Aalst, Simone Kool, Rien Van, Jack Dekker, M Hendriksen, R. A. Schoevers, Cecile Gijsbers-van Wijk, J. Peen, Frans De JongheAbstract:The efficacy of Short Psychodynamic Supportive Psychotherapy (SPSP) has not yet been compared with pharmacotherapy. A mega-analysis based on three original Randomized Clinical Trials (RCTs) was performed. Patients with (mild to moderate) major depressive disorder were randomized in (24 weeks) SPSP (n = 97), pharmacotherapy (n = 45), or their combination (n = 171). Efficacy was assessed by the Hamilton Depression Rating Scale (HDRS), Clinical Global Impression of Severity and of Improvement (CGI-S), the Symptom Checklist (SCL; depression subscale) and the Quality of Life Depression Scale (QLDS). Pearson χ2 calculations were used to compare success rates. Analyses of covariance (ANCOVAs) were used to test inter-group differences. Success rates indicated that independent observers (HDRS) found no differences in symptom reduction between SPSP and pharmacotherapy (P = 0.214), but therapists (CGI-S, P = 0.026), and patients (SCL, P = 0.036) favored SPSP. Combined therapy was found superior to pharmacotherapy by all three (patients (P = 0.000), therapists (P = 0.024), independent observers (P = 0.024)). Independent observers (P = 0.062) and therapists (P = 0.430) found no differences between combined therapy and SPSP, but patients (P = 0.016) found combined therapy to be superior. As far as quality of life is concerned, success rates indicated that patients (QLDS) found no differences between SPSP and pharmacotherapy (P = 0.073) or between SPSP and combined therapy (P = 0.217). However, they found combined therapy superior to pharmacotherapy (P = 0.015). The results of the mega-analysis suggest that combined therapy is more efficacious than pharmacotherapy. SPSP and pharmacotherapy seem equally efficacious, except for some indications that patients and therapists favor SPSP for symptom reduction. Combined therapy and SPSP also seem equally efficacious, except that patients think that the first is better in symptom reduction. Depression and Anxiety 0:1–10, 2007. © 2007 Wiley-Liss, Inc.
John C. Markowitz - One of the best experts on this subject based on the ideXlab platform.
-
What is Supportive Psychotherapy
FOCUS, 2014Co-Authors: John C. MarkowitzAbstract:This article reviews the meaning, use, and utility of Supportive Psychotherapy, a widespread treatment with an undeservedly malign birthright and history. This entails sorting through the historical definitions of Supportive therapy and reviewing its good research track record achieved despite being the comparison condition. The author then defines brief Supportive Psychotherapy (BSP), a manualized, “common factors” treatment that has fared well in research settings, which may provide a model for clinical and research use in the future.
-
pilot study of interpersonal Psychotherapy versus Supportive Psychotherapy for dysthymic patients with secondary alcohol abuse or dependence
Journal of Nervous and Mental Disease, 2008Co-Authors: John C. Markowitz, Kathryn L. Bleiberg, Paul J Christos, James H Kocsis, Alexandra CarlinAbstract:Abstract:Interpersonal Psychotherapy (IPT) has demonstrated efficacy for depression but yielded negative results for substance disorders. Alcohol abuse frequently complicates mood disorders. This pilot study compared IPT with brief Supportive Psychotherapy (BSP) for dysthymic disorder and alcohol ab
-
therapists responses to training in brief Supportive Psychotherapy
American Journal of Psychotherapy, 2008Co-Authors: John C. Markowitz, Rachel Manber, Phyllis RosenAbstract:There is little research addressing Supportive Psychotherapy training. This article describes training clinicians in a form of brief Supportive Psychotherapy (BSP) for a multisite depression study,...
-
Therapists' responses to training in brief Supportive Psychotherapy.
American Journal of Psychotherapy, 2008Co-Authors: John C. Markowitz, Rachel Manber, Phyllis RosenAbstract:There is little research addressing Supportive Psychotherapy training. This article describes training clinicians in a form of brief Supportive Psychotherapy (BSP) for a multisite depression study, and reports on a survey of therapist attitudes toward BSP. We hypothesized that while most therapists would report acclimating to BSP, cognitive-behavioral therapy (CBT)-trained therapists would report greater frustration with BSP. Sixteen (89%) of 18 therapists completed a brief questionnaire. Therapists reported gaining comfort with Supportive concepts and interventions. Therapists with cognitive behavior therapy orientations did not report significantly greater frustration with intervention restrictions. All practitioners indicated they were already using or were planning to use BSP outside the study, and that BSP training had altered their appreciation of Psychotherapy. Most study therapists lacked prior Supportive therapy training but reported adapting to BSP and appreciating its strengths and limitations.
-
Pilot Study of Interpersonal Psychotherapy Versus Supportive Psychotherapy for Dysthymic Patients With Secondary Alcohol Abuse or Dependence
The Journal of Nervous and Mental Disease, 2008Co-Authors: John C. Markowitz, Kathryn L. Bleiberg, Paul J Christos, James H Kocsis, Alexandra CarlinAbstract:Interpersonal Psychotherapy (IPT) has demonstrated efficacy for depression but yielded negative results for substance disorders. Alcohol abuse frequently complicates mood disorders. This pilot study compared IPT with brief Supportive Psychotherapy (BSP) for dysthymic disorder and alcohol abuse. We hypothesized that effect sizes would suggest greater IPT efficacy for both diagnoses, despite limited statistical power. Subjects with primary DSM-IV dysthymic disorder and secondary alcohol abuse/dependence were randomly assigned 16 weeks of IPT (N = 14) or BSP (N = 12). Patients in both treatments reported improved depressive symptoms and alcohol abstinence. IPT had a large and BSP a moderate effect size in depression, whereas BSP had a moderate and IPT a small effect size in percentage of days abstinent. This pilot study offers initial data on IPT and BSP for comorbid chronic depression and alcohol abuse/dependence. Results suggest IPT may have specific antidepressant benefits for dysthymic alcoholic patients but not in treating alcoholism.
Mariëlle Hendriksen - One of the best experts on this subject based on the ideXlab platform.
-
moderation of the alliance outcome association by prior depressive episodes differential effects in cognitive behavioral therapy and short term psychodynamic Supportive Psychotherapy
Behavior Therapy, 2017Co-Authors: Lorenzo Lorenzoluaces, Ellen Driessen, Mariëlle Hendriksen, Robert J Derubeis, John R Keefe, Jack DekkerAbstract:Abstract Prior studies have suggested that the association between the alliance and depression improvement varies as a function of prior history of depression. We sought to replicate these findings and extend them to short-term psychodynamic Supportive Psychotherapy (SPSP) in a sample of patients who were randomized to one of these treatments and were administered the Helping Alliance Questionnaire ( N = 282) at Week 5 of treatment. Overall, the alliance was a predictor of symptom change ( d = 0.33). In SPSP, the alliance was a modest but robust predictor of change, irrespective of prior episodes ( d = 0.25–0.33). By contrast, in CBT, the effects of the alliance on symptom change were large for patients with 0 prior episodes ( d = 0.86), moderate for those with 1 prior episode ( d = 0.49), and small for those with 2 + prior episodes ( d = 0.12). These findings suggest a complex interaction between patient features and common vs. specific therapy processes. In CBT, the alliance relates to change for patients with less recurrent depression whereas other CBT-specific processes may account for change for patients with more recurrent depression.
-
short term psychoanalytic Supportive Psychotherapy for depressed patients
Psychoanalytic Inquiry, 2013Co-Authors: Frans De Jonghe, Mariëlle Hendriksen, Simone Kool, Saskia De Maat, Rien Van, M Gerda D Van Aalst, Jack DekkerAbstract:Short-Term Psychoanalytic Supportive Psychotherapy (SPSP) is a face-to-face, individual Psychotherapy, consisting of sixteen sessions in six months (first eight weekly, then eight fortnightly sessions). It is rooted in psychoanalytic theory. Its primary aim is to cure depression. A secondary goal is to reduce a patient's vulnerability to depression. The emphasis is on Supportive techniques that counter regression and foster psychological growth. The putative process consists in experiencing a relational dissonance, i.e., feeling two contradictory relationships in the therapeutic situation simultaneously, one determined by the past, the other by the present. We assume an important curative factor is to experience, mostly unconsciously, an adequate gratification of developmental needs inadequately met in early infancy and, therefore, manifesting themselves in the archaic aspects of the therapeutic relationship. SPSP unfolds as a discourse in which we distinguish nine levels. Each regards a specific subject,...
-
Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial
BMC Psychiatry, 2007Co-Authors: Ellen Driessen, Henricus L. Van, Robert A. Schoevers, Pim Cuijpers, Gerda Van Aalst, Frank J. Don, Mariëlle Hendriksen, Simone Kool, Pieter J. Molenaar, Jaap PeenAbstract:Background: Previous research has shown that Short Psychodynamic Supportive Psychotherapy (SPSP) is an effective alternative to pharmacotherapy and combined treatment (SPSP and pharmacotherapy) in the treatment of depressed outpatients. The question remains, however, how Short Psychodynamic Supportive Psychotherapy compares with other established Psychotherapy methods. The present study compares Short Psychodynamic Supportive Psychotherapy to the evidence-based Cognitive Behavioral Therapy in terms of acceptability, feasibility, and efficacy in the outpatient treatment of depression. Moreover, this study aims to identify clinical predictors that can distinguish patients who may benefit from either of these treatments in particular. This article outlines the study protocol. The results of the study, which is being currently carried out, will be presented as soon as they are available. Methods/Design: Adult outpatients with a main diagnosis of major depressive disorder or depressive disorder not otherwise specified according to DSM-IV criteria and mild to severe depressive symptoms (Hamilton Depression Rating Scale score ≥ 14) are randomly allocated to Short Psychodynamic Supportive Psychotherapy or Cognitive Behavioral Therapy. Both treatments are individual psychotherapies consisting of 16 sessions within 22 weeks. Assessments take place at baseline (week 0), during the treatment period (week 5 and 10) and at treatment termination (week 22). In addition, a follow-up assessment takes place one year after treatment start (week 52). Primary outcome measures are the number of patients refusing treatment (acceptability); the number of patients terminating treatment prematurely (feasibility); and the severity of depressive symptoms (efficacy) according to an independent rater, the clinician and the patient. Secondary outcome measures include general psychopathology, general Psychotherapy outcome, pain, healthrelated quality of life, and cost-effectiveness. Clinical predictors of treatment outcome include
Lorenzo Lorenzoluaces - One of the best experts on this subject based on the ideXlab platform.
-
moderation of the alliance outcome association by prior depressive episodes differential effects in cognitive behavioral therapy and short term psychodynamic Supportive Psychotherapy
Behavior Therapy, 2017Co-Authors: Lorenzo Lorenzoluaces, Ellen Driessen, Mariëlle Hendriksen, Robert J Derubeis, John R Keefe, Jack DekkerAbstract:Abstract Prior studies have suggested that the association between the alliance and depression improvement varies as a function of prior history of depression. We sought to replicate these findings and extend them to short-term psychodynamic Supportive Psychotherapy (SPSP) in a sample of patients who were randomized to one of these treatments and were administered the Helping Alliance Questionnaire ( N = 282) at Week 5 of treatment. Overall, the alliance was a predictor of symptom change ( d = 0.33). In SPSP, the alliance was a modest but robust predictor of change, irrespective of prior episodes ( d = 0.25–0.33). By contrast, in CBT, the effects of the alliance on symptom change were large for patients with 0 prior episodes ( d = 0.86), moderate for those with 1 prior episode ( d = 0.49), and small for those with 2 + prior episodes ( d = 0.12). These findings suggest a complex interaction between patient features and common vs. specific therapy processes. In CBT, the alliance relates to change for patients with less recurrent depression whereas other CBT-specific processes may account for change for patients with more recurrent depression.
Ellen Driessen - One of the best experts on this subject based on the ideXlab platform.
-
moderation of the alliance outcome association by prior depressive episodes differential effects in cognitive behavioral therapy and short term psychodynamic Supportive Psychotherapy
Behavior Therapy, 2017Co-Authors: Lorenzo Lorenzoluaces, Ellen Driessen, Mariëlle Hendriksen, Robert J Derubeis, John R Keefe, Jack DekkerAbstract:Abstract Prior studies have suggested that the association between the alliance and depression improvement varies as a function of prior history of depression. We sought to replicate these findings and extend them to short-term psychodynamic Supportive Psychotherapy (SPSP) in a sample of patients who were randomized to one of these treatments and were administered the Helping Alliance Questionnaire ( N = 282) at Week 5 of treatment. Overall, the alliance was a predictor of symptom change ( d = 0.33). In SPSP, the alliance was a modest but robust predictor of change, irrespective of prior episodes ( d = 0.25–0.33). By contrast, in CBT, the effects of the alliance on symptom change were large for patients with 0 prior episodes ( d = 0.86), moderate for those with 1 prior episode ( d = 0.49), and small for those with 2 + prior episodes ( d = 0.12). These findings suggest a complex interaction between patient features and common vs. specific therapy processes. In CBT, the alliance relates to change for patients with less recurrent depression whereas other CBT-specific processes may account for change for patients with more recurrent depression.
-
Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial
BMC Psychiatry, 2007Co-Authors: Ellen Driessen, Henricus L. Van, Robert A. Schoevers, Pim Cuijpers, Gerda Van Aalst, Frank J. Don, Mariëlle Hendriksen, Simone Kool, Pieter J. Molenaar, Jaap PeenAbstract:Background: Previous research has shown that Short Psychodynamic Supportive Psychotherapy (SPSP) is an effective alternative to pharmacotherapy and combined treatment (SPSP and pharmacotherapy) in the treatment of depressed outpatients. The question remains, however, how Short Psychodynamic Supportive Psychotherapy compares with other established Psychotherapy methods. The present study compares Short Psychodynamic Supportive Psychotherapy to the evidence-based Cognitive Behavioral Therapy in terms of acceptability, feasibility, and efficacy in the outpatient treatment of depression. Moreover, this study aims to identify clinical predictors that can distinguish patients who may benefit from either of these treatments in particular. This article outlines the study protocol. The results of the study, which is being currently carried out, will be presented as soon as they are available. Methods/Design: Adult outpatients with a main diagnosis of major depressive disorder or depressive disorder not otherwise specified according to DSM-IV criteria and mild to severe depressive symptoms (Hamilton Depression Rating Scale score ≥ 14) are randomly allocated to Short Psychodynamic Supportive Psychotherapy or Cognitive Behavioral Therapy. Both treatments are individual psychotherapies consisting of 16 sessions within 22 weeks. Assessments take place at baseline (week 0), during the treatment period (week 5 and 10) and at treatment termination (week 22). In addition, a follow-up assessment takes place one year after treatment start (week 52). Primary outcome measures are the number of patients refusing treatment (acceptability); the number of patients terminating treatment prematurely (feasibility); and the severity of depressive symptoms (efficacy) according to an independent rater, the clinician and the patient. Secondary outcome measures include general psychopathology, general Psychotherapy outcome, pain, healthrelated quality of life, and cost-effectiveness. Clinical predictors of treatment outcome include